Brenda Gibson

6.8k total citations
74 papers, 2.8k citations indexed

About

Brenda Gibson is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Brenda Gibson has authored 74 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 39 papers in Public Health, Environmental and Occupational Health and 21 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Brenda Gibson's work include Acute Lymphoblastic Leukemia research (36 papers), Acute Myeloid Leukemia Research (34 papers) and Childhood Cancer Survivors' Quality of Life (18 papers). Brenda Gibson is often cited by papers focused on Acute Lymphoblastic Leukemia research (36 papers), Acute Myeloid Leukemia Research (34 papers) and Childhood Cancer Survivors' Quality of Life (18 papers). Brenda Gibson collaborates with scholars based in United Kingdom, Netherlands and United States. Brenda Gibson's co-authors include Keith Wheatley, Alan K. Burnett, Robert K. Hills, Christine J. Harrison, Ian Hann, Donald Milligan, Franklin O. Smith, Jeffrey E. Rubnitz, David Webb and Siebold S.N. de Graaf and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Brenda Gibson

71 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brenda Gibson United Kingdom 28 1.8k 1.2k 711 666 430 74 2.8k
Craig A. Hurwitz United States 31 1.1k 0.6× 1.4k 1.1× 1.2k 1.6× 626 0.9× 847 2.0× 64 3.6k
Alan Lichtin United States 27 1.9k 1.1× 771 0.6× 363 0.5× 487 0.7× 570 1.3× 101 3.8k
Bart J. Biemond Netherlands 30 2.4k 1.3× 509 0.4× 235 0.3× 982 1.5× 370 0.9× 126 3.7k
Karen L. Hagerty United States 13 330 0.2× 1.4k 1.1× 481 0.7× 431 0.6× 975 2.3× 18 3.2k
Samart Pakakasama Thailand 25 472 0.3× 408 0.3× 375 0.5× 434 0.7× 334 0.8× 130 1.6k
Antonio De Vivo Italy 35 1.9k 1.1× 271 0.2× 381 0.5× 942 1.4× 930 2.2× 90 3.9k
Finn Wesenberg Norway 28 738 0.4× 918 0.7× 917 1.3× 243 0.4× 219 0.5× 87 2.2k
Lori Luchtman‐Jones United States 27 945 0.5× 238 0.2× 275 0.4× 231 0.3× 228 0.5× 80 1.8k
Tim Littlewood United Kingdom 23 1.3k 0.7× 161 0.1× 75 0.1× 443 0.7× 345 0.8× 62 1.8k
R Zittoun France 15 595 0.3× 309 0.2× 175 0.2× 219 0.3× 421 1.0× 79 1.4k

Countries citing papers authored by Brenda Gibson

Since Specialization
Citations

This map shows the geographic impact of Brenda Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Gibson more than expected).

Fields of papers citing papers by Brenda Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Gibson. The network helps show where Brenda Gibson may publish in the future.

Co-authorship network of co-authors of Brenda Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Gibson. A scholar is included among the top collaborators of Brenda Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Gibson. Brenda Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stevens, Thomas, Jennifer Cassels, Claire Schwab, et al.. (2024). Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact‐independent mechanism. British Journal of Haematology. 206(3). 858–863.
2.
Wilson, Abbie, Ahmed Moussa, Amélie Trinquand, et al.. (2024). Real‐world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies. British Journal of Haematology. 205(6). 2355–2362.
3.
Lucchini, Giovanna, Caroline L. Furness, Sarah Lawson, et al.. (2021). COVID‐19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience. British Journal of Haematology. 194(4). e74–e77. 10 indexed citations
4.
Esteves, Cristina L., et al.. (2020). Reciprocal Regulation of HSD11B1 and HSD11B2 Predicts Glucocorticoid Sensitivity in Childhood Acute Lymphoblastic Leukemia. The Journal of Pediatrics. 220. 249–253. 5 indexed citations
5.
Harrison, Christine J., et al.. (2017). Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia. Experimental Hematology. 54. 40–50. 27 indexed citations
6.
Gabriel, Melissa, Bronwen E. Shaw, Ruta Brazauskas, et al.. (2017). Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). Biology of Blood and Marrow Transplantation. 23(8). 1320–1326. 5 indexed citations
7.
Burnett, Alan K., Nigel H. Russell, Robert K. Hills, et al.. (2013). Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial. Journal of Clinical Oncology. 31(27). 3360–3368. 289 indexed citations
8.
Kaspers, Gertjan J.L., Martin Zimmermann, Dirk Reinhardt, et al.. (2013). Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group. Journal of Clinical Oncology. 31(5). 599–607. 152 indexed citations
9.
Rubnitz, Jeffrey E., Brenda Gibson, & Franklin O. Smith. (2010). Acute Myeloid Leukemia. Hematology/Oncology Clinics of North America. 24(1). 35–63. 116 indexed citations
11.
Harrison, Christine J., Robert K. Hills, Anthony V. Moorman, et al.. (2010). Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12. Journal of Clinical Oncology. 28(16). 2674–2681. 194 indexed citations
12.
Goemans, Bianca F., C. Michel Zwaan, Jacqueline Cloos, et al.. (2010). FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657. Leukemia Research. 34(10). 1302–1307. 7 indexed citations
13.
Kaspers, Gertjan J.L., Martin Zimmermann, Dirk Reinhardt, et al.. (2010). Central Nervous System (CNS) Involvement In Pediatric Relapsed Acute Myeloid Leukemia: Results and Lessons From Study Relapsed AML 2001/01. Blood. 116(21). 184–184. 2 indexed citations
14.
Gibson, Brenda, Audrey Todd, Irene Roberts, et al.. (2004). Transfusion guidelines for neonates and older children. British Journal of Haematology. 124(4). 433–453. 229 indexed citations
15.
Chessells, Judith M., G Harrison, Susan Richards, et al.. (2002). Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI. British Journal of Haematology. 118(2). 445–455. 18 indexed citations
16.
Barr, Ronald D. & Brenda Gibson. (2000). Nutritional Status and Cancer in Childhood. ˜The œAmerican journal of pediatric hematology/oncology. 22(6). 491–494. 10 indexed citations
19.
Reilly, John J., Jennifer Weir, John H. McColl, & Brenda Gibson. (1999). Prevalence of Protein‐Energy Malnutrition at Diagnosis in Children with Acute Lymphoblastic Leukemia. Journal of Pediatric Gastroenterology and Nutrition. 29(2). 194–197. 2 indexed citations
20.
Macdonald, P., et al.. (1992). Protein C activity in severely ill newborns with congenital heart disease. Journal of Perinatal Medicine. 20(6). 421–427. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026